Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
Year: 2020
Type: article
Source: Leukemia
Authors: Evangelos Terpos, Monika Engelhardt, Gordon Cook, Francesca Gay, Maria-Victoria Mateos, Ioannis Ntanasis-Stathopoulos, Niels W. C. J. van de Donk, Hervé Avet-Loiseau, Roman Hajek, Annette Juul Vangsted, Heinz Ludwig, Sonja Zweegman, Philippe Moreau, Hermann Einsele, Mario Boccadoro, Jesus San Miguel, Meletios A. Dimopoulos, Pieter Sonneveld
Institutions: National and Kapodistrian University of Athens, University of Freiburg, National Health Service, University of Leeds, Leeds Teaching Hospitals NHS Trust, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, Consejo Superior de Investigaciones Científicas, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Amsterdam University Medical Centers, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Institut universitaire du cancer de Toulouse Oncopole, University of Ostrava, University Hospital Ostrava, Copenhagen University Hospital, Rigshospitalet, Wilhelminen Hospital, Universitätsklinikum Würzburg, Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Centro de Investigación Médica Aplicada, Erasmus MC Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: multiple myeloma, COVID-19 pandemic, SARS-CoV-2, immunocompromised patients, personalized treatment, autologous stem cell transplantation, allogeneic stem cell transplantation, oral agents, expectant management, relapsed multiple myeloma, treatment interruption, quarantine, telemedicine, patient education
Open Access status: green
Award: G414919524
OpenAlex ID: W3028330817
